Related references
Note: Only part of the references are listed.Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial
Corinne Faivre-Finn et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
Alessio Bruni et al.
FRONTIERS IN ONCOLOGY (2021)
Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection-can local recurrence be radically cured by radiation?
Yukihiro Terada et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)
Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer
Sukki Cho et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)
KRAS-Mutant non-small cell lung cancer: From biology to therapy
Irene Ferrer et al.
LUNG CANCER (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Management of stage I and II nonsmall cell lung cancer
Fiona McDonald et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
European position statement on lung cancer screening
Matthijs Oudkerk et al.
LANCET ONCOLOGY (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Incidence and mortality of lung cancer: global trends and association with socioeconomic status
Martin C. S. Wong et al.
SCIENTIFIC REPORTS (2017)
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Nonesmall-cell Lung Cancer Developing After Surgery
Shinji Nakamichi et al.
CLINICAL LUNG CANCER (2017)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. E. Postmus et al.
ANNALS OF ONCOLOGY (2017)
Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non-Small-Cell Lung Cancer
Tomoyoshi Takenaka et al.
CLINICAL LUNG CANCER (2015)
Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry
Florian Kocher et al.
LUNG CANCER (2015)
Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody
Ross Stewart et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer
Tokujiro Yano et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial
Nanda Horeweg et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Chemoradiotherapy for Locoregional Recurrence of Non-Small-Cell Lung Cancer After Surgical Resection: A Retrospective Analysis
Jair Bar et al.
CLINICAL LUNG CANCER (2013)
Local recurrence following lung cancer surgery: Incidence, risk factors, and outcomes
David Fedor et al.
SURGICAL ONCOLOGY-OXFORD (2013)
Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy
Shinsuke Saisho et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2013)
Tumor Recurrence After Complete Resection for Non-Small Cell Lung Cancer
Matthew D. Taylor et al.
ANNALS OF THORACIC SURGERY (2012)
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
Anne Auperin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Impact of Local Treatment Against Postoperative Oligometastases in Non-Small Cell Lung Cancer
Tokujiro Yano et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Local Recurrence After Surgery for Early Stage Lung Cancer An 11-Year Experience With 975 Patients
Chris R. Kelsey et al.
CANCER (2009)
Postrecurrence survival in patients with stage I non-small cell lung cancer
Tatsuo Nakagawa et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2008)
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
Jan P. van Meerbeeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection
Hiroshi Sugimura et al.
ANNALS OF THORACIC SURGERY (2007)
Local recurrence following initial resection of NSCLC: Salvage is possible with radiation therapy
Chris R. Kelsey et al.
CANCER JOURNAL (2006)
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean-Yves Douillard et al.
LANCET ONCOLOGY (2006)
Share Paper
